Sudarshan Pharma Industries saw a 4% stock price increase after reporting a 44.8% rise in Q4 net profit to ₹10.73 crore and a 36.72% revenue growth to ₹220.92 crore. For the year, net profit rose 55.64% and sales climbed 39.21%.